1. Home
  2. ONC vs LULU Comparison

ONC vs LULU Comparison

Compare ONC & LULU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • LULU
  • Stock Information
  • Founded
  • ONC 2010
  • LULU 1998
  • Country
  • ONC Switzerland
  • LULU Canada
  • Employees
  • ONC N/A
  • LULU N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • LULU Apparel
  • Sector
  • ONC Health Care
  • LULU Consumer Discretionary
  • Exchange
  • ONC Nasdaq
  • LULU Nasdaq
  • Market Cap
  • ONC 26.9B
  • LULU 28.2B
  • IPO Year
  • ONC N/A
  • LULU 2007
  • Fundamental
  • Price
  • ONC $250.30
  • LULU $236.71
  • Analyst Decision
  • ONC Strong Buy
  • LULU Buy
  • Analyst Count
  • ONC 9
  • LULU 27
  • Target Price
  • ONC $325.56
  • LULU $334.18
  • AVG Volume (30 Days)
  • ONC 345.1K
  • LULU 3.6M
  • Earning Date
  • ONC 08-06-2025
  • LULU 08-28-2025
  • Dividend Yield
  • ONC N/A
  • LULU N/A
  • EPS Growth
  • ONC N/A
  • LULU 18.31
  • EPS
  • ONC N/A
  • LULU 14.75
  • Revenue
  • ONC $4,175,868,000.00
  • LULU $10,749,895,000.00
  • Revenue This Year
  • ONC $869.15
  • LULU $8.23
  • Revenue Next Year
  • ONC $19.07
  • LULU $7.16
  • P/E Ratio
  • ONC N/A
  • LULU $16.04
  • Revenue Growth
  • ONC 51.16
  • LULU 9.39
  • 52 Week Low
  • ONC $146.21
  • LULU $219.97
  • 52 Week High
  • ONC $287.88
  • LULU $423.32
  • Technical
  • Relative Strength Index (RSI)
  • ONC N/A
  • LULU 38.07
  • Support Level
  • ONC N/A
  • LULU $232.09
  • Resistance Level
  • ONC N/A
  • LULU $241.84
  • Average True Range (ATR)
  • ONC 0.00
  • LULU 7.02
  • MACD
  • ONC 0.00
  • LULU 2.29
  • Stochastic Oscillator
  • ONC 0.00
  • LULU 51.87

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

About LULU lululemon athletica inc.

Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 760 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 40 franchised locations in the Middle East. The company was founded in 1998 and is based in Vancouver, Canada.

Share on Social Networks: